Research analysts at Morgan Stanley initiated coverage on shares of Irhythm Technologies Inc (NASDAQ:IRTC) in a research note issued to investors on Monday. The firm set an “overweight” rating on the stock.

A number of other analysts also recently commented on the company. JPMorgan Chase & Co. initiated coverage on Irhythm Technologies in a report on Monday. They set an “overweight” rating for the company. Canaccord Genuity assumed coverage on Irhythm Technologies in a report on Monday. They issued a “buy” rating for the company. Finally, BTIG Research assumed coverage on Irhythm Technologies in a report on Monday. They issued a “buy” rating for the company.

Shares of Irhythm Technologies (NASDAQ:IRTC) opened at 24.23 on Monday. Irhythm Technologies has a one year low of $22.16 and a one year high of $28.00. The stock’s market capitalization is $35.21 million. The firm’s 50-day moving average price is $24.75 and its 200-day moving average price is $24.75.

5 Day Chart for NASDAQ:IRTC

Receive News & Stock Ratings for Irhythm Technologies Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Irhythm Technologies Inc and related stocks with our FREE daily email newsletter.